IOVA vs AMGN: Which Stock is Better?
Side-by-side comparison of Iovance Biotherapeutics Inc and Amgen Inc in 2026
IOVA
Iovance Biotherapeutics Inc
$3.64
AMGN
Amgen Inc
$350.95
Key Metrics Comparison
| Metric | IOVA | AMGN | Winner |
|---|---|---|---|
| Market Cap | $1.43B | $188.58B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.24 | AMGN |
| Revenue Growth | 0.2% | 0.1% | IOVA |
| Gross Margin | 34.3% | 70.8% | AMGN |
Analyze IOVA
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IOVA or AMGN a better investment?
Comparing IOVA and AMGN: Iovance Biotherapeutics Inc has a market cap of $1.43B while Amgen Inc has $188.58B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IOVA and AMGN?
IOVA (Iovance Biotherapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IOVA or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IOVA or AMGN?
IOVA has higher revenue growth at 0.2% vs 0.1% for AMGN.
Which company is more profitable: IOVA or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 34.3% for IOVA.
Which is the larger company: IOVA or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.58B compared to $1.43B for IOVA.
Should I buy IOVA or AMGN in 2026?
Both IOVA and AMGN have investment merit. IOVA trades at $3.64 while AMGN trades at $350.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IOVA and AMGN stock?
Key differences: Market Cap ($1.43B vs $188.58B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.2% vs 0.1%), Gross Margin (34.3% vs 70.8%).